Tehran University of Medical Sciences
home | Farsi
Print

ali khalaj

Contact Information
Tel: +982166959098
Fax: +982188962007
Address: ِDepartment of medicinal chemistry- Faculty of Pharmacy
Academic Rank
Professor
School
Emeritus Faculty
Medicinal Chemistry
About
CV last edited on: 2016/19/12

1.

Ph.D


Ph.D, Philadelphia College of Pharmacy and Sciences, Major in Medicin, Tehran, IRAN, 1976
2.


M.Sc, Philadelphia College of Pharmacy and Sciences, Major in Pharmace, Tehran, IRAN, 1973
3.

Pharm D


Pharm.D , University of Tehran Major in Pharmacy, Tehran, IRAN, 1968
1.

some German


2.

English


3.

Persian


Scientific Position

1.

Professor of Medicinal Chemistry Faculty of Pharmacy


Tehran University of Medical Sciences, 1976-present
2.

College of Pharmacy


Memorial University of Newfoundland, St .John, s Canada, 2001-2002

-

1.

Teaching Courses in Radiopharmacy


-.
2.

Medicinal Chemistry


-.
3.

and Research Advisor of Pharm.D and Graduate Students


-.
4.

Teaching Courses in General Chemistry


-.
5.

Analytical Chemistry


-.
6.

Medicinal Chemistry


-.
7.

Radiopharmacy,Advanced Medicinal Chemistry


-.
8.

Synthesis and Identification of Organic Compounds


-.

Papers

English

1.

Fe3+-Tryptophan-3-Hydroxy-2-Methyl or ethyl pyridinones Towards Novel Molecular Tumor Nuclear Resonance Imaging Agents


Authors: Ali Khalaj, Shadi Hosseini, Rahimeh Rasouli, Artin Assadi, Seyedeh Ghoreishi and Mehdi Shafiee Ardestani
Letters in Drug Design & Discovery, Year. 2016,
2.

Preparation and Biological Study of 68Ga-DOTA-alendronate


Authors: Ashraf Fakhari, Amir R. Jalilian, Fariba Johari-Daha, Mehdi Shafiee-Ardestani, and Ali Khalaj
Asia Ocean J Nucl Med Biol, Year. 2016,
3.

Preparation and preclinical evaluation of 68Ga-DOTA-amlodipine for L-type calcium channel imaging


Authors: Tahereh Firuzyar, Amir Reza Jalilian, Mohammad Reza Aboudzadeh, Hossein Sadeghpour, Mahdi Shafiee-Ardestani, Ali Khalaj
IJNM, Year. 2016,
4.

Preparation of a 153Sm-5,10,15,20-tetrakis(4-methoxyphenyl) porphyrin complex as a possible therapeutic agent


Authors: Nasim Vahidfar, Amir Reza Jalilian, Yousef Fazaeli, Ali Bahrami-Samani, Davood Beiki, Ali Khalaj
Iranian Journal of Nuclear Medicine, Year. 2015,
5.

Production, quality control, biodistribution assessment and preliminary dose evaluation of 166Ho-alendronate as a bone marrow ablative agent


Authors: Ashraf Fakhari, Amir Reza Jalilian, Hassan Yousefnia, Samaneh Zolghadri, Ali Bahrami Samani, Mahmoud Reza Akbari, Fariba Johari Deha, Mahdi Shafiee-Ardestani, Ali Khalaj
International Journal for chemical aspects of nuclear science and technology, Year. 2015,
6.

Preparation and preliminary biological evaluation of [153Sm] samarium AMD3100; towards a possible therapeutic chemokine receptor CXCR4 targeting complex


Authors: Ayuob Aghanejad, Amir Reza Jalilian, Ali Bahrami-Samani, Davood Beiki, Stephan Maus, Ali Khalaj
Iranian Journal of Nuclear Medicine, Year. 2015,
7.

Radiosynthesis and Animal Studies of 111In-DTPA-bis-alendronate Complex


Authors: Ashraf Fakhari, Amir R. Jalilian, Mahdi Shafiee Ardestani, Fariba Johari Deha, Mohammad Mirzaie, Sedigheh Moradkhan, Ali Khalaj
Biomedical Technologies , Year. 2015,
8.

Development of Radiolanthanide-Labeled-Bis- Alendronate Complexes for Bone Pain Palliation Therapy


Authors: Fakhari A, Jalilian AR, Yousefnia H, Shafiee- Ardestani M, Johari-Daha F, Mazidi M and Khalaj A
J Nucl Med Radiother, Year. 2015,
9.

Radiolabeling and evaluation of two 177Lu-labeled bis-phosphonates


Authors: Ashraf Fakhari, Amir R.Jalilian, Hassan Yousefnia, Ali Bahrami-Samani; Fariba Johari-Daha, Ali Khalaj
Iranian Journal of Nuclear Medicine, Year. 2015,
10.

Preparation, Biological Evaluation and Dosimetry Studies of 175Yb-Bis-Phosphonates for Palliative Treatment of Bone Pain


Authors: Ashraf Fakhari, Amir R.Jalilian, Hassan Yousefnia,, Shanehsazzadeh S, Samani AB, Daha FJ, Ardestani MS, Khalaj A
Mol Imaging Radionucl Ther, Year. 2015,
11.

Development of 166Ho-pamidronate for bone pain palliation therapy


Authors: Ashraf Fakhari, Amir R.Jalilian, Hassan Yousefnia, Fariba Johari –Daha, Mohammad Mazidi, Ali Khalaj
J Radioanaly Nuclear Chem , Year. 2014,
12.

Effect Of Hydrophilic SolventsS On Enhancing Transdermal Delivery of Albumin


Authors: Narges Shokri, Hamid Akbari Javar, Ali Khalaj
IJPSR, Year. 2014,
13.

Preparation and radiolabeling of a lyophilized (kit) formulation of DOTA-rituximab with 90Y and 111In for domestic radioimmunotherapy and radioscintigraphy of Non-Hodgkin’s Lymphoma


Authors: Nazila Gholipour, Amir Reza Jalilian, Ali Khalaj, Fariba Johari-Daha
DARU Journal of Pharmaceutical Sciences, Year. 2014,
14.

Preparation and preliminary biological evaluation of radioligand – labeled DTPA –amlodipine complex for possible L-type Calcium channel imaging


Authors: Tahereh Firouzyar,Amir R. Jalillian,Yousef Fazeli, Mohammad Shafiee Ardestani, Mohammad Reza Aboudzadeh,and Ali Khalaj
Radiochimica Acta , Year. 2014,
15.

Development of [62Zn/62Cu]-DOTA-rituximab as a possible novel in vivo PET generator for anti-CD20 antigen imaging


Authors: Nazila Gholipour / Amir R. Jalilian / Yousef Fazaeli / Omid Sabzevari/ Sedigheh Moradkhani/ Fateme Bolourinovin/ Ali Khalaj
Radiochimica Acta, Year. 2014,
16.

Radiosynthesis and biodistribution studies of [62Zn/62Cu]–plerixafor complex as a novel in vivo PET generator for chemokine receptor imaging


Authors: Ayuob Aghanezhad, Amir R Jalilian, Yousef Fazaeli, Davood beiki, Behrooz Fateh, Ali Khalaj
Journal of Radioanalytical and Nuclear Chemistry, Year. 2014,
17.

Synthesis and Evaluation of [(67)Ga]-AMD3100: A Novel Imaging Agent for Targeting the Chemokine Receptor CXCR4.


Authors: Aghanejad A, Jalilian AR, Fazaeli Y2, Alirezapoor B, Pouladi M, Beiki D, Maus S Khalaj A
Sci.Pharm, Vol.82, No.1, Year. 2014, Number of Page:13
18.

Radiosynthesis and biological evaluation of 166Ho labeled


Authors: • Nasim Vahidfar,Amir R.Jalilian,Yousef Fazaeli,Ali Bahrami Samani,Davood Beiki, Ali Khalaj
J Radioanal Nucl Chem, Vol.301, Year. 2013, Page:269-276,
19.

Development of radiolanthanide labeled porphyrin complexes as possible therapeutic agents in beast carcinoma xenografts


Authors: Nasim Vahidfar / Amir R. Jalilian / Yousef Fazaeli / Ayuob Aghanejad / Ali Bahrami-Samani/ Behrooz Alirezapour/ Mostafa Erfani / Davood Beiki/ Ali Khalaj
Radiochimica Acta, Vol.102, No.7, Year. 2013, Page:29,
20.

Synthesis, in vitro aerobic and hypoxic cytotoxicity and radiosensitizing activity of novel metronidazole tethered 5-fluorouracil


Authors: Khosrou Abdi , Ali khalaj , Seyed Nasser Ostad, Navid Lamei , Mohammad Reza Khoshayand
DARU Journal of Pharmaceutical Sciences, Year. 2013,
21.

Radiosynthesis and Quality Control of [67Ga]-3,4-dimethoxylated Porphyrin Complex as a Possible Imaging agent


Authors: Azadeh Paknafas, Yousef Fazaeli, Amir Reza Jalilian, Abbas Ahmadi, Shahzad Feizi, Mohsen Kamalidehghan, Ali Rahiminejad, Ali Khalaj
Iranian Journal of Pharmaceutical Research, Vol.12, Year. 2013,
22.

Synthesis, In Vitro Cytotoxicity and Radiosensitizing Activity of Novel 3-[(2,4-Dinitrophenylamino)Alkyl] Derivatives of 5-Fluorouracil


Authors: Ali Khalaj, Khosrou Abdi, Seyed Nasser Ostad, Mohammad Reza Khoshayand, Navid Lamei, Hasan Ali Nedaie
Chemical Biology & Drug Design, Year. 2013,
23.

Development and evaluation of a 166holmium labelled porphyrin complex as a possible therapeutic agent


Authors: Nassim Vahidfar , Amir R. Jalilian , Yousef Fazaeli, Ali Bahrami-Samani, Davood Beiki , Ali Khalaj
Radioanal Nucl Chem, Vol.295, Year. 2013,
24.

In Vitro and In Vivo Evaluation of Poly(Caprolactone Fumarate) Nanoparticles


Authors: N. Shokri, E. Azizi, H. Akbari Javar, Sh. Fouladdel, A. Khalaj, R. Dinarvand
IJPSR, Vol.3, Year. 2012,
25.

Cytotoxicity and radiosensitising activity of synthesized dinitrophenyl derivatives of 5-fluorouracil


Authors: Khosrou Abdi, Ali Khalaj, Syeed-Naser Ostad,Mohammad Reza Khoshayand
DARU Journal of Pharmaceutical Sciences, Vol.20, Year. 2012,
26.

Interaction of 5-Fluorouracil and its derivatives with bovine serum albumin


Authors: Abdi K, Nafisi Sh, Manouchehri F, Bonsaii M, Khalaj A
Photochem Photobiol B, Vol.107, Year. 2012,
27.

Preparation and evaluation of poly(caprolactone fumarate) nanoparticles containing doxorubicin HCl


Authors: N Shokri, H Akbari Javar, Sh Fouladdel, A Khalaj, MR Khoshayand, R Dinarvand, F Atyabi, A Nomani, E Azizi,
DARU, Vol.1, Year. 2011, Number of Page:12-22
28.

KhalajThe impact of substituentson isatin ring on the reaction between isatins with ortho-phenylenediamine


Authors: R. Dowlatabadi, A.Khalaj
Syn.Communi, Vol.41, Year. 2011, Number of Page:1650-1658
29.

ForoumadiDiscovery of a novel nitroimidazolyleoxazolidinone hybrid with potent anti Gram-positive activity: Synthesis and pp. 1e6 antibacterial evaluation


Authors: Khalaj, M.Nakhjiri, A S. Negahbani, M.Samadizadeh, L. Firoozpour, SRajabalian, N.Samadi,M. AFaramarzi, N.Adibpour, A. Shafiee, AR
Eur J Med Chem , Vol.46, Year. 2011, Number of Page:65-70
30.

Preparation and characterization of crosslinked and non-crosslinked polycaprolactone fumarate (PCLF) NPs as carriers for doxorubicin HCl


Authors: Narges Shokri, Hamid Akbari Javar, Shamileh Fouladdel, Ali Khalaj, Rasoul Dinarvand and Ebrahim Azizi
African Journal of Pharmacy and Pharmacology, Vol.5, No.7, Year. 2011, Number of Page:797-805
31.

Synthesis and cytotoxicity of some biurets against human breast cancer T47D cell line


Authors: S.Fouladdel, A.Khalaj, N.Adibpour, E.Azizi
Bioorg Med Chem Lett, Vol.20, No.5772, Year. 2010,
32.

.Initial and delayed stress phase imaging in a single-injection double-acquisition SPECT


Authors: D.Beiki,B.Fallahi, Z.Mohseni, A.Khalaj, A.Fard-Esfahani,M.Eftekhari
Schattauer, Vol.19, Year. 2010, Number of Page:19-27
33.

Synthesis and antibacterial activity of isothiazolyl oxazolidinones and analogous 3(2H) isothiazolones


Authors: N.Adibpour, A.Khalaj, A.Rajabalian
Eur J Med Chem , Vol.45, Year. 2010, Number of Page:19-24
34.

Synthesis and radioprotective study of novel amino-alkyldithiocarbamic acid derivatives against – irriadiation in mice


Authors: S.J.Hosseinimehr,D.Beiki, A.Kebriaeezadeh, A.Khalaj,M.Pirali,Hammedani,,S.Akhlaghpour, H.Esmaeili, A.R.Barazesh
Iran.J.Radiat.Res, Vol.7, No.2, Year. 2009, Number of Page:91-96
35.

Investigation of Selective Cytotoxicity and Determination of Ligand Induced Apoptosis of a New Acenaphto[1,2-b] Quinoxaline Derivatives


Authors: E. Mahjoob, A. Khalaj, S.N. Ostad S.N, E .Azizi E, Fouladdel S, Tavajohi S, Salehi R, Dowlatabadi R
Arzneimittel Forschungmg , Vol.59, Year. 2009, Number of Page:526-531
36.

Correlation between lipophilicity and antimicrobial activity of some 2-(4-substituted phenyl )-3(2H)-isothiazolones


Authors: S. Rezaee, A. Khalaj, N. Adibpour, M. Saffary
DARU, Vol.17, Year. 2009, Number of Page:263
37.

Medicinal Chemistry


Authors: A.Safiee, A.Khalaj, K.Javidnia, H.Sadeghi-aliabadi, M.Amanloo, R.Miri
انتشارات دانشگاه علوم پزشكي شيراز, Vol.1, Year. 2009,
38.

Synthesis and Evaluation of in vitro Anti-tuberculosis Activity of N-Substituted Glycolamides


Authors: F. Daryaee ,F.Kobarfard A Khalaj, P. Farnia
Eur J Med Chem, Vol.44, Year. 2009, Number of Page:289-295
39.

Ultrasound promoted N-alkylation and N-acylation of 2,4-dinitro-phenylamine


Authors: A.Khalaj, A.R.Doroudi, N.Adibpour, J.Mohseni
Asian.J.Chem , Vol.21, Year. 2009, Number of Page:997-1001
40.

Formation And Ring Contraction Of 1,2- Benzothiazepine-1,1 Dioxides From And To 1,2-Benzothiazine-1,1-Dioxides, Syn


Authors: A.khalaj, N.Adibpour
Communi, Vol.38, Year. 2008, Number of Page:3662-3671
41.

Between Different Lipophilicity Parameters And Antimycobacterial Activities Of 2-Hydroxyacetamides


Authors: F. Kobarfard, A. Khalaj, F.Daryaee, Z. Ardeshir Larijany, S. RezaeeCorrelation
DARU, Vol.16, Year. 2008, Number of Page:55-59
42.

Textbook of Nuclear Pharmacy


Authors: F.Atyabi,M.H.Babaei, D.Beiki, A.Cheraghali,R. Dowlatabadi-Bazaz, K.Haghir-Ebrahimabadi, S.J.Hosseinimehr, A.R.Jalilian, F. Johari, A.Khalaj, R.Najafi, A,Owlia.,
انتشارات دانشگاه علوم پزشكي تهران, Year. 2007,
44.

In vitro Antifungal Activity of Isothiazolone 3-ones


Authors: A.khalaj, N.Adibpour
Folia Microbiol , Vol.52, No.573, Year. 2007,
45.

Qualitative assessment of the views of graduate and undergraduate students of the faculty of pharmacy about pharmaceutical research in Iran


Authors: A . Khalaj, K.Shokraiee, P.Seyfi, B.Mesgarpour, H.R Adhami;
Hakim, Vol.9, No.45, Year. 2006,
46.

A theory of mode of action of azolylalkylquinolines as DNA binding agents using Automated flexible ligand docking


Authors: A. Madadkar Sobhani, S. Rasoul Amini , J. D.A. Tyndall , E. Azizi , M. Daneshtalab , A. Khalaj
J Mol Graph Model , Vol.25, No.459, Year. 2006,
47.

Anti-Tumor Activity of New Quinoline Derivatives in Human Breast Cancer T47D Cells


Authors: S.Rasoul-Amini, A.Khalaj, A.Shafiee, M.Daneshtalab, A.Madadkar-Sobhani, S.Fouladdel, E.Azizi
Int J Canc Res , Vol.2, No.102, Year. 2006,
48.

Synthesis, aerobic cytotoxicity, and radiosensitizing activity of novel 2,4-dinitrophenylamine tethered 5-fluorouracil and hydroxyurea


Authors: A.Khalaj , A. R .Doroudi ,S. Ostad, M. R. Khoshayand, M. Babai ,N.Adibpour
Bioorg Med Chem Lett, Vol.16, No.6034, Year. 2006,
49.

Radipharmaceutical Regulation World Wide - the Resemblances and the Differences


Authors: R.Dowlatabadi Bazaz, D.Beiki, A.Khalaj
Iran J Nucl Med , Vol.21, No.23, Year. 2005,
50.

Synthesis and Antimycobacterial Activity of 2-Hydroxyacetamides


Authors: F.Daryaee, F.Kobarfard, A.Khalaj, P.Farnia;
Daru, Vol.13, No.94, Year. 2005,
51.

Validation of 13C-Urea Breath Test with Non Dispersive Isotope Selective Infrared Spectroscopy for the Diagnosis of Helicobacter Pylori Infection: A Survey in Iranian Population


Authors: D.Beiki, A.Khalaj, R.Dowlatabadi Bazaz, M.Eftekhari, M.H.Al-Seyed Hossein, A.Fard, B.Fallahi, M.R.Khoshayand;
Daru, Vol.13, No.52, Year. 2005,
52.

Microdose 14C Urea Breath Test for the Diagnosis of Helicobacter Pylori/ A Survey in Iranian Population


Authors: R.Dowlatabadi Bazaz, A.Khalaj, D.Beki, M.Eftekhari, M.H.Al-Seyed Hosein, M.R.Khoshayand;
Daru, Vol.13, No.6, Year. 2005,
53.

Synthesis and Antibacterial Activity of 2-(4-Substituted Phenyl)- 3(2H)-Isothiazolones


Authors: A.Khalaj, N.Adibpour, A.Shahverdi, M.Daneshtalab
Eur J Med Chem , Vol.39, No.699, Year. 2004,
54.

Inhibitation and Activation Studies of Histidine Decarboxylase From Lactobacillus 30a By Imidazolidine 4-One Derivatives Using A pH-Stat Technique


Authors: B.Farzami, A.Ghassemieh, E.Elmi Akhoundi, A.Khalaj , R.Dowlatabadi;
Iranian J Sci Tech Transaction A, Vol.27, Year. 2003,
55.

Synthesis of radioiodinated labeled peptides


Authors: M.Matloobi, H.Rafii, D.Beigi, M.Kamali-Dehghan
Journal of Radioanalytical an Nuclear Chemistry, Vol.257, No.71-73, Year. 2003,
56.

Increased selectivity in inflammatory site identification via labelling of IgG with N-succinimidyl-4-[125I]iodobenzoate


Authors: Davood Beiki, Soraya Shahhosseini, Ali Khalaj, Mohammad Eftekari;
J Label Compd Radiopharmacy , Vol.45, No.1, Year. 2002,
59.

NMR evidence for cationic behaviour of the benzotriazole ring in novel a- ( benzotriazol –1-yl ) –N-acylglycines


Authors: A.Khalaj, M. Pirali, R. Dowlatabadi
J Chem Research, Vol.412, Year. 2001,
60.

A New and Simple Synthesis ofN-Succinimidyl- 4- [ 127 ,125 I ] Iodobenzoate Involving A Microwave - Accelerated Iodination


Authors: A. Khalaj, D. Beiki, H. Rafiee, R. Najafi
J Labelled Compounds and Radiopharm , Vol.44, No.235, Year. 2001,
61.

A Short and Efficient Synthesis of Novel N ( 2,3-dihydro-2-oxo-5-phenyl -1H -1,4 -benzodizepin -3-yl ) -2- carboxamide


Authors: A. Khalaj, M. Pirali, H. Matloubi, R. Dowlatabadi;
Monatshefte fur Chemi , Vol.32, No.747, Year. 2001,
62.

Effects of Acute and Chronic Lithium on Morphine Induced Analgesia in Mice by Formalin Tes


Authors: M. Sharifzadeh, H.R. Sadeghipour, F. Khjou, A. Khalaj, M. Abdollahi
Acta Medica Iranica , Vol.37, No.37, Year. 1999,
63.

Molecular Modelling and Hypothermie Activity of Dantrolene Sodium and two Corresponding Analogues


Authors: A. Khalaj, M. Sharifzadeh, H. Shadnia
Pharm Pharmacol Commun , Vol.5, No.91, Year. 1999,
65.

Synthesis, Molecular Modeling and In-Vitro Antibacterial Activity of 4- Amino- a- hydroxybenzeneacetamides


Authors: A. Khalaj, H. Shadnia, M.Sharifzadeh
Pharm Pharmacol Commun , Vol.4, No.373, Year. 1998,
66.

Cyclic Acetal-Like Derivaties of Diclofenac; Synthesis and In-Vivo Evaluation in Rats


Authors: A.Khalaj, M. Amanlou, M.Jorjani
Pharm Pharmacol Commun , Vol.4, No.201, Year. 1998,
67.

A New Synthesis ofa-HydroxyCarboxylates and 2-Hydroxybenzoates


Authors: A. Khalaj, R. Aboofazeli
Iran J Chem & Chem Eng , Vol.16, No.1, Year. 1997,
68.

Synthesis of Novel Imidazolidinones


Authors: A. khalaj, R.D. Bazaz, M. Shekarchi
Monashefte Fur Chemie , Vol.128, No.395, Year. 1997,
69.

Synthesis and Photo physical Properties of Fluorescent 2-Aryl-1, 3-Dialkylbenzimidazolium Ions and1-Alkyl-2-Arylbenzimidazoles with Excited State Intramolecular Proton Transfer


Authors: J.M. Kauffman, A.Khalaj, P.T. Litiak, J.A. Novinski, G.S.Gajwa
J Heterocycl Chem , Vol.31, No.957, Year. 1994,
70.

New Synthesis of Unsubstituted 4 (5) and 4,5-Substituted1-H-imidazoles


Authors: A.Khalaj, M.Ghaffari
Tet Lett , Vol.27, No.50, Year. 1986,
71.

Synthesis ofa- Hydroxy acid amides from Acetonides of a-Hydroxy acids and Amines


Authors: A.Khalaj, E. Nahid;
Synthesis , Vol.12, No.1153, Year. 1985,
72.

Structure - Activity Relationship of 2, 3-Dihydro-1, 4-Benzothiazines.Iran


Authors: A. Khalaj;
J. Chem & Chem Eng , Vol.5, No.20, Year. 1985,
73.

Studies on the Chemistry of Pharmacologically Active Heterocyclic.Part I, Acid Hydrolysis of Hydrazino-1, 2, 4- triazine- derivatives


Authors: M. Daneshtalab, A. Khalaj, and I. Lalezari
J. Heterocyclic. Chem, Vol.16, No.817, Year. 1979,
74.

Electrochemical Evidence for Interaction between Chlorpromazine Hydrochloride and Trifluoperazine Hydrochloride and the Flavin Coenzymes


Authors: L.A. Delisser-Matthews , A. Khalaj;
J. Pharm. Sci, Vol.65, No.1758, Year. 1976,

Farsi

1.

Synthesis and Muscle Relaxant Activity of two Analogues of Dantrolene Sodium in Mice


Authors: A. Khalaj, H.R. Rastegi, M.Jorjani;
Pharm Pharmacol Commun , Vol.4, No.477, Year. 1998,
1.

Chem Draw


2.

Word


1.

Sigma Xi


Activity Type:Others
2.

Member of the Editorial Board of Iranian Journal of Chemistry and Chemical Engineering


Activity Type:Member
2006-2012
3.

Member of the Editorial Board of DARU,J. of Pharmaceutical Sciences ,Tehran University of Medical Sciences


Activity Type:Member
2000-present
4.

Member of Pharmaceutical Sciences group, Iranian Academy of Medical Sciences Chief Editor


Activity Type:Member
2000-2012
5.

Research Associate Department of Chemistry University of Alberta, Canada


Activity Type:Member
1979 -1980
6.

Research Associate, College of Pharmacy, Purdue University, U.S.A


Activity Type:Member
1977-1978
7.

An active member of Tehran University promotional Counci


Activity Type:Member
1998 -present
8.

.Member of the University of the Tehran Higher Council


Activity Type:Member
1975-1977
1. Isothiazolones
2. (Synthesis and biological activity of 3(2H
3. Radiosensythizers
4. Prodrugs
Top